Loading...
HomeSearchMy WebLinkAboutMA21-01 - COVID19 Vaccine And Idaho Medicaid - RESCINDEDMA21-02 - Consumer-Directed Service Delivery Flexibilities in Response to COVID-19MA21-03 - COVID19 CFAC Medicaid Provider Stabilization Fund - RESCINDEDMA21-04 - Annual WAHR Survey 2021MA21-05 - Therapy Cap LimitsMA21-06 - COVID19: NEMT Providers - Vaccination Priority Group Clarification = RESCINDEDMA21-07 - Change In Hospital Reimbursement MethodologyMA21-08 - Change In Nursing Facility Reimbursement Methodology - AMENDEDMA21-09 - COVID19 Healthy Connections Referral Requirements ReinstatementMA21-10 - New Medicaid Provider Rate Review ProcessMA21-11 - Swingbed & AND Rates 2021MA21-12 - Changes to HC Primary Care Program 2021MA21-13 - HC Value Care ProgramMA21-14 - COVID19 CFAC Medicaid Provider Stabilization Fund - RESCINDEDMA21-15 - Home Health CapsMA21-16 - Conflict Free Case ManagementMA21-17 - ARPA HCBS Spending PlanMA21-18 - April & May 2021 P&T Committee Update to Preferred Drug List (PDL)MA21-19 - COVID19 Modified SBS, CHIS, & Children's DD Service Delivery FlexibilitiesMA21-20 - COVID19 CFAC Medicaid Provider Stabilization Fund - RESCINDEDMA21-22 - Adult DD QA GuidanceMA21-23 COVID19 Laboratory and Pathology ServicesMA21-24 - Hospice Rates 2022MA21-25 COVID19 Vaccine And Idaho Medicaid - RESCINDEDMA21-26 COVID19 Monoclonal Antibody TreatmentMA21-28 Change In Outpatient Hospital Reimbursement Methodology - APCMA21-29 2022 Therapy Cap LimitsMA21-30 Pharmacy PDL - October and November 2021